Detection of gene mutations in kanamycin-resistant Mycobacterium tuberculosis and development of the method for rapid diagnosis

耐卡那霉素结核分枝杆菌基因突变检测及快速诊断方法的建立

基本信息

项目摘要

In Mycobacterium smegmatis and a limited number of Mycobacterium tuberculosis strains, the involvement of alterations of the 16S rRNA gene (rrs) in resistance to kanamycin has been shown. To investigate the extent to which mutations in a specific region of the n-s gene and the kanamycin-resistant phenotype in clinically isolated M.tuberculosis swains were correlated, 43 kanamycin-resistant swains (MICs, >=200 mu g/ml), 71 kanamycin-susceptible strains, and 4 type strains were examined. The 300-bp DNA fragments carrying the rrs gene and the intervening sequence between the rrs gene and 23S rRNA (rrl) gene fragments were amplified by PCR and were subjected to PCR-based direct sequencing. By comparing the nucleotide sequences, substitutions were found in 29 of 43 (67.4%) kanamycin-resistant clinical isolates at position 1400, 1401 and 1483 but in none of the 71 sensitive isolates or the 4 type strains. The most frequent substitution, from A to G, occurred at position 1400. A substitution from C to T at position 1401 was found once. Two clinical isolates carried the double mutation from C to A at position 1401 and from G to T at position 1483. In addition, we found that these mutations can be distinguished from wild-type strains by digestion with the restriction endonucleases Tai I and Tsp 451. Furthermore, we found that the genotypes of kanamycin-resistant swains can be discriminated from each other by digestion with a restriction endonuclease, Bst UI or Dde I.
在污垢分枝杆菌和数量有限的结核分枝杆菌菌株中,16S rRNA基因(RRS)的改变已被证明与卡那霉素耐药有关。为探讨结核分枝杆菌临床分离株中n-S基因特定区域突变与卡那霉素耐药表型的相关性,对43株卡那霉素耐药株、71株卡那霉素敏感株和4株卡那霉素敏感株进行了检测。用聚合酶链式反应(PCR)扩增出携带RRS基因的300bpDNA片段和RRS基因与23S rRNA(RRL)基因之间的插入序列,并进行直接测序。通过核苷酸序列比较,发现43株卡那霉素耐药临床分离株中有29株(67.4%)在1400、1401和1483位发生了突变,而71株敏感株和4种类型菌株均未发生突变。最频繁的替换,从A到G发生在1400位。一次在1401位发现了从C到T的替换。2株临床分离株携带1401位C到A和1483位G到T的双重突变。此外,我们还发现用限制性内切酶TAI和TSP451可以将这些突变与野生型菌株区分开来。此外,我们还发现,用限制性内切酶BST-UI或Dde-I可以区分卡那霉素抗性野生型。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chihiro Katsukawa, Aki Tamaru, Yoshihito Miyata, Chiyoji Abe, Masanao Makino, and Yasuhiko Suzuki: "Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolate of Mycobacterium tuberculosis in Japan." J.Appl.Microbiol.83. 634-640
Chihiro Katsukawa、Aki Tamaru、Yoshihito Miyata、Chiyoji Abe、Masanao Makino 和 Yasuhiko Suzuki:“日本结核分枝杆菌链霉素耐药临床分离株的 rpsL 和 rrs 基因的特征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chihiro Katsukawa: "A comprebensive report of the state of tuberculosis in Japan" Journal of Antibacterial and Antifungal Agents. 27. 315-335 (1999)
Chihiro Katsukawa:“日本结核病状况的综合报告”抗菌和抗真菌药物杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kyongsu Hong and Chihiro Katsukawa: "Expression and Characterization of a Recombinant M3 Ploypeptide encoding Amino acids 42 through 517 of M3 protein" Immunology and Infectious Diseases. 6. 207-214 (1996)
Kyongsu Hong 和 Chihiro Katsukawa:“编码 M3 蛋白氨基酸 42 至 517 的重组 M3 多肽的表达和表征”免疫学和传染病。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chihiro Katsukawa: "A comprehensive report of the state of tuberculosis in Japan"Journal of Antibacterial and Antifungal Agents. 27. 315-335 (1999)
Chihiro Katsukawa:“日本结核病状况的综合报告”抗菌和抗真菌药物杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chihiro Katsukawa: "Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan." Journal of Applied Microbiology. 83. 634-640 (1997)
Chihiro Katsukawa:“日本结核分枝杆菌链霉素耐药临床分离株的 rpsL 和 rrs 基因的特征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATSUKAWA Chihiro其他文献

KATSUKAWA Chihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATSUKAWA Chihiro', 18)}}的其他基金

Development of pyrazinamide susceptilbility testing method for Mycobacterium tuberculosis by using gene analysis technique
利用基因分析技术建立结核分枝杆菌吡嗪酰胺药敏检测方法
  • 批准号:
    11670404
  • 财政年份:
    1999
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cloning and nucleotide sequence of the drug resistant genes and its application to rapid identification.
耐药基因的克隆、核苷酸序列及其快速鉴定应用。
  • 批准号:
    05670378
  • 财政年份:
    1993
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

High-throughput profiling of proteases with phage and arrays
使用噬菌体和阵列对蛋白酶进行高通量分析
  • 批准号:
    10602245
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Mechanisms of Oculomotor Influences on Hearing
动眼神经影响听力的机制
  • 批准号:
    10598103
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity
重新利用莫洛替尼预防氨基糖苷类引起的耳毒性
  • 批准号:
    10554341
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Ordered gene knockout libraries for Neisseria gonorrhoeae
有序的淋病奈瑟菌基因敲除文库
  • 批准号:
    10088802
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
A small RNA regulation of virulence in Lyme disease pathogen
莱姆病病原体毒力的小RNA调节
  • 批准号:
    10218725
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Ordered gene knockout libraries for Neisseria gonorrhoeae
有序的淋病奈瑟菌基因敲除文库
  • 批准号:
    10437587
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Macrolide resistance transfer in Streptococcus pyogenes
化脓性链球菌中的大环内酯类耐药性转移
  • 批准号:
    10474268
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
In-Vivo Monitoring of Therapeutic Drug Transport Across Biological Barriers
治疗药物跨生物屏障转运的体内监测
  • 批准号:
    10677650
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity
重新利用莫洛替尼预防氨基糖苷类引起的耳毒性
  • 批准号:
    10341150
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Ordered gene knockout libraries for Neisseria gonorrhoeae
有序的淋病奈瑟菌基因敲除文库
  • 批准号:
    10649487
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了